Study IDs Barriers to Eye Screening Among Adults With Diabetes
By Lori Solomon HealthDay Reporter
TUESDAY, Nov. 28, 2023 -- Food insecurity, housing insecurity, mental health concerns, and the perceived importance of practitioner concordance are associated with a lower likelihood of receiving eye care among adults with diabetes, according to a study published online Nov. 16 in JAMA Ophthalmology.
Rohith Ravindranath, from Stanford University in Palo Alto, California, and colleagues evaluated associations between visiting an eye care practitioner for diabetic retinopathy screening and factors related to overall health and social determinants of health. The analysis included 11,551 adults with type 2 diabetes participating in the All of Us Research Program.
The researchers found that individuals who thought practitioner concordance was somewhat or very important were less likely to have seen an eye care practitioner (somewhat important: adjusted odds ratio [aOR], 0.83; very important: aOR, 0.85). Individuals with food or housing insecurity were less likely to visit an eye care practitioner (food insecurity: aOR, 0.75; housing insecurity: aOR, 0.86) compared with financially stable participants. Compared with individuals who reported good mental health, those who reported fair mental health were less likely to visit an eye care practitioner (aOR, 0.84).
"Such findings highlight the self-reported barriers to seeking care and the importance of taking steps to promote health equity," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted November 2023
Read this next
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.